Zobrazeno 1 - 10
of 54
pro vyhledávání: ''
Publikováno v:
The American Journal of Medicine. 132:e844-e845
Ranolazine is an anti-angina agent with many metabolites creating the potential for off-target effects. The U.S. Food and Drug Administration (FDA) reviews sometimes contain clinically relevant data not found in other sources.We reanalyzed data in an
Publikováno v:
The American Journal of Medicine. 128:120-125
Angiotensin-converting enzyme inhibitors (ACE-I) are widely used, effective, and well-tolerated antihypertensive agents. The mechanisms by which those agents act can cause side effects such as decreased blood pressure, hyperkalemia, and impaired rena
Autor:
Peter Libby, Paul M. Ridker
Publikováno v:
The American Journal of Medicine. 116:9-16
Inflammation participates critically in atherosclerosis. Circulating levels of several inflammatory markers rise in individuals at risk for atherosclerotic events. In particular, elevation of plasma C-reactive protein (CRP), a nonspecific acute-phase
Publikováno v:
The American Journal of Medicine. 114:347-353
Purpose Lipoprotein (a) [Lp(a)] levels increase in patients with renal disease. We administered niceritrol, a nicotinic acid derivative, to patients with chronic renal disease and a high serum Lp(a) level, and studied its effects on lipid metabolism,
Publikováno v:
The American Journal of Medicine. 110:13-19
Conventional nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to treat pain and inflammation but are frequently associated with gastrointestinal side effects, including life-threatening bleeding or perforation of gastroduodenal ulcers.
Publikováno v:
The American Journal of Medicine. 106:650-654
PURPOSE: We sought to describe the characteristics of a group of patients with idiopathic nonhistaminergic angioedema and their response to prophylactic treatment with tranexamic acid. METHODS: We identified 25 patients (15 men and 10 women; age at d
Publikováno v:
The American Journal of Medicine. 99:497-504
Purpose To determine whether angiotensin-converting enzyme (ACE) inhibition with captopril reduces the progression of microalbuminuria to overt proteinuria in normotensive patients with insulin-dependent diabetes mellitus (IDDM). Patients and methods
Publikováno v:
The American journal of medicine. 126(2)
The treatment of immunoglobulin A (IgA) nephropathy with normal renal function and minimal proteinuria is unknown.We randomly assigned 60 patients with IgA nephropathy, proteinuria0.5 g/day, normal blood pressure and renal function to ramipril 2.5 mg
Autor:
Michael M. Frank
Publikováno v:
The American Journal of Medicine. 113:249-251
Fremeaux-Bacchi et al. (1), in their study of hereditary angioedema, stand on the shoulders of a research lineage spanning well over a century. A rare disease, hereditary angioedema has been an important “experiment of nature,” allowing us to lea
Publikováno v:
The American Journal of Medicine. 95:169-175
purpose: In this study, we investigated the clinical and biochemical features and the responses to treatment of eight patients with auto-antibody-mediated Cl inhibitor (C1-INH) deficiency and symptoms of angioedema. patients and methods: In addition